2014 | BioSenic

2014 Annual Report

Read more about 2014 Annual Report

Bone Therapeutics to present at Biotech Showcase in San Francisco on Tuesday 14 January, 2014 at 10.15am

Read more about Bone Therapeutics to present at Biotech Showcase in San Francisco on Tuesday 14 January, 2014 at 10.15am

Bone Therapeutics Starts Patient Treatment in First Ever Clinical Trial with Allogeneic Bone Cell Therapy Product

Read more about Bone Therapeutics Starts Patient Treatment in First Ever Clinical Trial with Allogeneic Bone Cell Therapy Product

Bone Therapeutics and Partners awarded over €0.5 million M-ERA.net research funding to develop 3-D patient-tailored bone tissue engineered products

Read more about Bone Therapeutics and Partners awarded over €0.5 million M-ERA.net research funding to develop 3-D patient-tailored bone tissue engineered products

Bone Therapeutics supports pioneering research by backing projects vital to regenerative medicine research (EN)

Read more about Bone Therapeutics supports pioneering research by backing projects vital to regenerative medicine research (EN)

Bone Therapeutics receives clearance for ALLOB® phase II trial in spine fusion

Read more about Bone Therapeutics receives clearance for ALLOB® phase II trial in spine fusion

Bone Therapeutics extends ALLOB® phase I/IIa trial to Germany

Read more about Bone Therapeutics extends ALLOB® phase I/IIa trial to Germany

Bone Therapeutics and Kasios to collaborate on novel product for the optimisation of spinal fusion procedures

Read more about Bone Therapeutics and Kasios to collaborate on novel product for the optimisation of spinal fusion procedures

Bone Therapeutics Authorised to Enrol patients in the UK in Pivotal Phase III Osteonecrosis Trial with PREOB®

Read more about Bone Therapeutics Authorised to Enrol patients in the UK in Pivotal Phase III Osteonecrosis Trial with PREOB®

Subscribe to 2014